Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial

Bernhard Gentner, MD, Maria Ester Bernardo, MD PhD, Francesca Tucci, MD, Erika Zonari, PhD, Francesca Fumagalli, MD, Silvia Pontesilli, MD, Serena Acquati, PhD, Paolo Silvani, MD, Fabio Ciceri, MD, Attilio Rovelli, MD, Giancarlo La Marca, PhD, Rossella Parini, MD, Silvia Gregori, PhD, Eugenio Montini, PhD, Luigi Naldini, MD PhD, Alessandro Aiuti, MD PhD

Blood (2019) 134 (Supplement_1): 607.

https://doi.org/10.1182/blood-2019-128805

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Blood (2019) 134 (Supplement_1): 5830.

https://doi.org/10.1182/blood-2019-127402

Published: 2019

Journal Articles

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Renee Cheng, MD, Rishi Patel, MD, Sandra Kang, MD, Frances Tian, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Jayleen Patel, MD, Netanel Zilberstein, MD, Victor R Gordeuk, MD, Michel Gowhari, DO

Blood (2019) 134 (Supplement_1): 3396.

https://doi.org/10.1182/blood-2019-130877

Published: 2019

Journal Articles

Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis

Aafke E. Gaartman, MD, Ajab K. Sayedi, BSc, Charlotte F.J. Van Tuijn, MPH, PhD, Harriet Heijboer, MD PhD, Tanja Netelenbos, MD PhD, Bart J. Biemond, MD PhD, Erfan Nur, MD PhD

Blood (2019) 134 (Supplement_1): 1024.

https://doi.org/10.1182/blood-2019-130248

Published: 2019

Journal Articles

Prevention and Management of Tumor Lysis Syndrome in Patients with CLL and Coexisting Conditions Treated with Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Results from the Randomized CLL14 Trial

Othman Al-Sawaf, MD, Anna-Maria Fink, MD, Sandra Robrecht, PhD, Arijit Sinha, PhD, Maneesh Tandon, MD, Barbara F. Eichhorst, MD, Kirsten Fischer, MD, Michael Hallek, MD

Blood (2019) 134 (Supplement_1): 4315.

https://doi.org/10.1182/blood-2019-126570

Published: 2019

Journal Articles

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Christopher Melani, MD, Rahul Lakhotia, MD, Stefania Pittaluga, MD PhD, Milos D. Miljkovic, MDMSc, Jagan R. Muppidi, MD PhD, Craig A. Portell, MD, Rafic Farah, MD, Seung Tae Lee, MD PhD, Anna Marie Juanitez, RN, Lydia L. Chou, CRNP, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Louis Staudt, MD, Mark Roschewski, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 2867.

https://doi.org/10.1182/blood-2019-125990

Published: 2019

Journal Articles

Intravenous Fluid Boluses Are Commonly Administered to Adults with Sickle Cell Disease and Vaso-Occlusive Pain

Marcus A. Carden, MD, Paula Tanabe, PhDRN, Jeffrey A. Glassberg, MD

Blood (2019) 134 (Supplement_1): 4839.

https://doi.org/10.1182/blood-2019-121744

Published: 2019

Journal Articles

Use of Fluid and Oxygen Therapy in Normoaxaemic Paediatric Patients Presenting with Acute Sickle Vaso-Occlusive Episodes Requiring Hospital Admission and Analysis of Clinical Outcome

Zain Butt, BSc, Subarna Chakravorty, PhDFRCPath MRCP MRCPCH

Blood (2019) 134 (Supplement_1): 4844.

https://doi.org/10.1182/blood-2019-125708

Published: 2019

Journal Articles

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Shashank Sama, MBBS, Varun Tandon, Nikhila Kethireddy, Prajwal Boddu, MD

Blood (2019) 134 (Supplement_1): 4850.

https://doi.org/10.1182/blood-2019-122179

Published: 2019

Journal Articles

Outcomes Related to Intravenous Fluid Administration in Sickle Cell Patients during Vaso-Occlusive Crisis

Daria Gaut, MD, Jennifer Jones, MD, Caroline Chen, MD, Sanaz Ghafouri, MD, Mei Ling, MD, Roswell Quinn, MD PhD

Blood (2019) 134 (Supplement_1): 992.

https://doi.org/10.1182/blood-2019-121945

Published: 2019

Journal Articles

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Wallace Jones, MD, Leann Myers, Aditi Dasgupta, Jessica Debord

Blood (2019) 134 (Supplement_1): 3383.

https://doi.org/10.1182/blood-2019-127097

Published: 2019

Journal Articles

A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Farhad Ravandi, MD, Anthony S. Stein, MD, Hagop M. Kantarjian, MD, Roland B. Walter, MD PhD MS, Peter Paschka, MD, Mojca Jongen-Lavrencic, MD PhD, Gert J. Ossenkoppele, MD PhD, Zhao Yang, Bhakti Mehta, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 25.

https://doi.org/10.1182/blood-2018-99-109762

Published: 2018

Journal Articles

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Nadirah El-Amin, MPH, DO, Paul Nietert, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2018-99-117206

Published: 2018

Journal Articles

Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Tara Gregory, MD, Adam D. Cohen, MD, Caitlin L. Costello, MD, Syed Abbas Ali, MD, Jesus G. Berdeja, MD, Eric M Ostertag, MD PhD, Christopher Martin, PhD, Devon J Shedlock, PhD, Michelle Lynn Resler, BS, Matthew A. Spear, MD, Robert Z. Orlowski, MD PhD, Krina K. Patel, MDMSc

Blood (2018) 132 (Supplement 1): 1012.

https://doi.org/10.1182/blood-2018-99-111419

Published: 2018

Journal Articles

A Rare Case of Delirium: Acquired Thrombotic Thrombocytopenic Purpura in an HIV Patient

Kinjal Solanki, MD BA, Syed Haris A Pir, MD, Constantine Khoury, Jose F. Cervantes, MD

Blood (2018) 132 (Supplement 1): 5007.

https://doi.org/10.1182/blood-2018-99-120231

Published: 2018

Journal Articles

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Taylor Hanson, Ravi Patel, DO, Nitasa Sahu, MD, Zain Ayaz, MD, Julie Caler, Pharm.D, Kirk Jones, Pharm.D, Rohit Jain, MBBS

Blood (2018) 132 (Supplement 1): 4966.

https://doi.org/10.1182/blood-2018-99-112705

Published: 2018

Journal Articles

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Brian Pennarola, MD, Patrick Demartino, MD, Dale W. Steele, MD, Susan J. Duffy, MD

Blood (2018) 132 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2018-99-117703

Published: 2018

Journal Articles

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

Lauren E Lee, MD, Bradley W Beeler, MD, Aaron T Henderson, DO, Brendan C Graham, MD, Michael B Osswald, MD, Nay Win, MBBS, FRCP, FRCPath, CTM (Edin), Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2018-99-110529

Published: 2018

Journal Articles

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Blood (2018) 132 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2018-99-120049

Published: 2018

NARROW

Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis

Prevention and Management of Tumor Lysis Syndrome in Patients with CLL and Coexisting Conditions Treated with Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Results from the Randomized CLL14 Trial

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Intravenous Fluid Boluses Are Commonly Administered to Adults with Sickle Cell Disease and Vaso-Occlusive Pain

Use of Fluid and Oxygen Therapy in Normoaxaemic Paediatric Patients Presenting with Acute Sickle Vaso-Occlusive Episodes Requiring Hospital Admission and Analysis of Clinical Outcome

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Outcomes Related to Intravenous Fluid Administration in Sickle Cell Patients during Vaso-Occlusive Crisis

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM)

A Rare Case of Delirium: Acquired Thrombotic Thrombocytopenic Purpura in an HIV Patient

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only